Roger Crystal - Net Worth and Insider Trading

Roger Crystal Net Worth

The estimated net worth of Roger Crystal is at least $2 Million dollars as of 2024-05-06. Roger Crystal is the CEO, 10% Owner of Opiant Pharmaceuticals Inc and owns about 75,339 shares of Opiant Pharmaceuticals Inc (OPNT) stock worth over $2 Million. Details can be seen in Roger Crystal's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Roger Crystal has not made any transactions after 2023-01-27 and currently still holds the listed stock(s).

Transaction Summary of Roger Crystal

To

Roger Crystal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Roger Crystal owns 2 companies in total, including Opiant Pharmaceuticals Inc (OPNT) , and Mind Medicine Inc (MNMD) .

Click here to see the complete history of Roger Crystal’s form 4 insider trades.

Insider Ownership Summary of Roger Crystal

Ticker Comapny Transaction Date Type of Owner
OPNT Opiant Pharmaceuticals Inc 2023-01-27 director & 10 percent owner & Chief Executive Officer
MNMD Mind Medicine Inc 2022-08-11 director

Roger Crystal Latest Holdings Summary

Roger Crystal currently owns a total of 1 stock. Roger Crystal owns 75,339 shares of Opiant Pharmaceuticals Inc (OPNT) as of January 27, 2023, with a value of $2 Million.

Latest Holdings of Roger Crystal

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OPNT Opiant Pharmaceuticals Inc 2023-01-27 75,339 20.65 1,555,750

Holding Weightings of Roger Crystal


Roger Crystal Form 4 Trading Tracker

According to the SEC Form 4 filings, Roger Crystal has made a total of 7 transactions in Opiant Pharmaceuticals Inc (OPNT) over the past 5 years, including 1 buys and 6 sells. The most-recent trade in Opiant Pharmaceuticals Inc is the sale of 1,358 shares on January 27, 2023, which brought Roger Crystal around $27,513.

Insider Trading History of Roger Crystal

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Roger Crystal Trading Performance

GuruFocus tracks the stock performance after each of Roger Crystal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Roger Crystal is 41.65%. GuruFocus also compares Roger Crystal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Roger Crystal within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Roger Crystal's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Roger Crystal

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.93
Relative Return to S&P 500(%) -1.88

Roger Crystal Ownership Network

Ownership Network List of Roger Crystal

No Data

Ownership Network Relation of Roger Crystal


Roger Crystal Owned Company Details

What does Opiant Pharmaceuticals Inc do?

Who are the key executives at Opiant Pharmaceuticals Inc?

Roger Crystal is the director & 10 percent owner & Chief Executive Officer of Opiant Pharmaceuticals Inc. Other key executives at Opiant Pharmaceuticals Inc include other: General Counsel Brian Gorman , Chief Scientific Officer Phil Skolnick , and other: UK Managing Director Ellison Mark Jason Heath .

Opiant Pharmaceuticals Inc (OPNT) Insider Trades Summary

Over the past 18 months, Roger Crystal made 3 insider transaction in Opiant Pharmaceuticals Inc (OPNT) with a net sale of 7,570. Other recent insider transactions involving Opiant Pharmaceuticals Inc (OPNT) include a net sale of 2,885 shares made by Ellison Mark Jason Heath , a net sale of 2,556 shares made by David D O'toole , and a net sale of 2,270 shares made by Phil Skolnick .

In summary, during the past 3 months, insiders sold 0 shares of Opiant Pharmaceuticals Inc (OPNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,038 shares of Opiant Pharmaceuticals Inc (OPNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,038 shares.

Opiant Pharmaceuticals Inc (OPNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Opiant Pharmaceuticals Inc Insider Transactions

No Available Data

Roger Crystal Mailing Address

Above is the net worth, insider trading, and ownership report for Roger Crystal. You might contact Roger Crystal via mailing address: 445 Park Ave, 10th Fl., New York Ny 10022.

Discussions on Roger Crystal

No discussions yet.